Haemonetics (HAE) reported fiscal Q1 adjusted earnings Thursday of $1.14 per diluted share, up from $1.10 a year earlier.

Analysts polled by FactSet expected $0.87.

Net revenue for the quarter ended June 27 was $339.4 million, compared with $321.4 million a year earlier.

Analysts expected $327.9 million.

The company raised its fiscal 2027 outlook and now expects 5% to 8% growth in both revenue and adjusted EPS, from 4% to 7% previously. Analysts expect adjusted EPS of $4.50 on revenue of $1.40 billion.

Shares of Haemonetics were down more than 1% premarket Thursday.